312 related articles for article (PubMed ID: 9771481)
1. Longitudinal evaluation of cytogenetic aberrations in prostatic cancer: tumours that recur in time display an intermediate genetic status between non-persistent and metastatic tumours.
Alers JC; Krijtenburg PJ; Hop WC; Bolle WA; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H
J Pathol; 1998 Jul; 185(3):273-83. PubMed ID: 9771481
[TBL] [Abstract][Full Text] [Related]
2. Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone.
Alers JC; Krijtenburg PJ; Rosenberg C; Hop WC; Verkerk AM; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H
Lab Invest; 1997 Nov; 77(5):437-48. PubMed ID: 9389787
[TBL] [Abstract][Full Text] [Related]
3. DNA in situ hybridization (interphase cytogenetics) versus comparative genomic hybridization (CGH) in human cancer: detection of numerical and structural chromosome aberrations.
Van Dekken H; Krijtenburg PJ; Alers JC
Acta Histochem; 2000 Feb; 102(1):85-94. PubMed ID: 10726167
[TBL] [Abstract][Full Text] [Related]
4. Numerical abnormalities of chromosome 7 in human prostate cancer detected by fluorescence in situ hybridization (FISH) on paraffin-embedded tissue sections with centromere-specific DNA probes.
Zitzelsberger H; Szücs S; Weier HU; Lehmann L; Braselmann H; Enders S; Schilling A; Breul J; Höfler H; Bauchinger M
J Pathol; 1994 Apr; 172(4):325-35. PubMed ID: 8207613
[TBL] [Abstract][Full Text] [Related]
5. Aneusomy of chromosomes 7, 8, and 17 and amplification of HER-2/neu and epidermal growth factor receptor in Gleason score 7 prostate carcinoma: a differential fluorescent in situ hybridization study of Gleason pattern 3 and 4 using tissue microarray.
Skacel M; Ormsby AH; Pettay JD; Tsiftsakis EK; Liou LS; Klein EA; Levin HS; Zippe CD; Tubbs RR
Hum Pathol; 2001 Dec; 32(12):1392-7. PubMed ID: 11774175
[TBL] [Abstract][Full Text] [Related]
6. Identification of numerical chromosome aberrations in archival tumours by in situ hybridization to routine paraffin sections: evaluation of 23 phaeochromocytomas.
Van Dekken H; Bosman FT; Teijgeman R; Vissers CJ; Tersteeg TA; Kerstens HM; Vooijs GP; Verhofstad AA
J Pathol; 1993 Nov; 171(3):161-71. PubMed ID: 8277366
[TBL] [Abstract][Full Text] [Related]
7. Histological preservation after in situ hybridization to archival solid tumour sections allows discrimination of cells bearing numerical chromosome changes.
van Dekken H; Kerstens HM; Tersteeg TA; Verhofstad AA; Vooijs GP
J Pathol; 1992 Nov; 168(3):317-24. PubMed ID: 1469508
[TBL] [Abstract][Full Text] [Related]
8. Intratumoural cytogenetic heterogeneity of sporadic colorectal carcinomas suggests several pathways to liver metastasis.
Sayagués JM; Abad Mdel M; Melchor HB; Gutiérrez ML; González-González M; Jensen E; Bengoechea O; Fonseca E; Orfao A; Muñoz-Bellvis L
J Pathol; 2010 Jul; 221(3):308-19. PubMed ID: 20527024
[TBL] [Abstract][Full Text] [Related]
9. [Significance of numerical chromosome aberrations in prostate cancer].
Henke RP; Krüger E; Ayhan N; Hübner D; Hammerer P
Verh Dtsch Ges Pathol; 1993; 77():133-7. PubMed ID: 7511271
[TBL] [Abstract][Full Text] [Related]
10. Fluorescence in situ hybridization analysis of matched primary tumour and lymph-node metastasis of D1 (pT2-3pN1M0) prostate cancer.
Alcaraz A; Corral JM; Ribal MJ; Mallofré C; Mengual L; Carrió A; Gil-Vernet Sedó JM; Villavicencio H
BJU Int; 2004 Aug; 94(3):407-11. PubMed ID: 15291877
[TBL] [Abstract][Full Text] [Related]
11. Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progression.
Qian J; Hirasawa K; Bostwick DG; Bergstralh EJ; Slezak JM; Anderl KL; Borell TJ; Lieber MM; Jenkins RB
Mod Pathol; 2002 Jan; 15(1):35-44. PubMed ID: 11796839
[TBL] [Abstract][Full Text] [Related]
12. Chromosomal anomalies in stage D1 prostate adenocarcinoma primary tumors and lymph node metastases detected by fluorescence in situ hybridization.
Gburek BM; Kollmorgen TA; Qian J; D'Souza-Gburek SM; Lieber MM; Jenkins RB
J Urol; 1997 Jan; 157(1):223-7. PubMed ID: 8976257
[TBL] [Abstract][Full Text] [Related]
13. Clinical and pathological significance of numerical aberrations of chromosomes 11 and 17 in colorectal neoplasms.
Tagawa Y; Yasutake T; Sawai T; Nanashima A; Jibiki M; Morinaga M; Akama F; Nakagoe T; Ayabe H
Clin Cancer Res; 1997 Sep; 3(9):1587-92. PubMed ID: 9815847
[TBL] [Abstract][Full Text] [Related]
14. Interphase cytogenetic analysis of prostatic carcinomas by use of nonisotopic in situ hybridization.
Baretton GB; Valina C; Vogt T; Schneiderbanger K; Diebold J; Löhrs U
Cancer Res; 1994 Aug; 54(16):4472-80. PubMed ID: 8044798
[TBL] [Abstract][Full Text] [Related]
15. Detection of chromosomal anomalies and c-myc gene amplification in the cribriform pattern of prostatic intraepithelial neoplasia and carcinoma by fluorescence in situ hybridization.
Qian J; Jenkins RB; Bostwick DG
Mod Pathol; 1997 Nov; 10(11):1113-9. PubMed ID: 9388062
[TBL] [Abstract][Full Text] [Related]
16. Correlation of numerical chromosome 11 and 17 imbalance with metastasis of primary breast cancer to lymph nodes.
Herrington CS; Leek RD; McGee JO
J Pathol; 1995 Aug; 176(4):353-9. PubMed ID: 7562250
[TBL] [Abstract][Full Text] [Related]
17. Cytogenetic heterogeneity and histologic tumor growth patterns in prostatic cancer.
Alers JC; Krijtenburg PJ; Vissers CJ; Bosman FT; van der Kwast TH; van Dekken H
Cytometry; 1995 Sep; 21(1):84-94. PubMed ID: 8529477
[TBL] [Abstract][Full Text] [Related]
18. HER-2 status in primary oesophageal cancer, lymph nodes and distant metastases.
Schoppmann SF; Jesch B; Zacherl J; Wrba F; Hejna M; Maresch J; Langer FB; Riegler MF; Pluschnig U; Birner P
Br J Surg; 2011 Oct; 98(10):1408-13. PubMed ID: 21618213
[TBL] [Abstract][Full Text] [Related]
19. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization.
Jenkins RB; Qian J; Lieber MM; Bostwick DG
Cancer Res; 1997 Feb; 57(3):524-31. PubMed ID: 9012485
[TBL] [Abstract][Full Text] [Related]
20. Selection toward diploid cells in prostatic carcinoma derived cell cultures.
Ketter R; Zwergel T; Romanakis K; Unteregger G; Ziegler M; Zang KD; Wullich B
Prostate; 1996 Jun; 28(6):364-71. PubMed ID: 8650073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
